Sensor Assembly for Drug Delivery End-of-Dose Detection

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Drug delivery devices lack features to accurately confirm the administration of medicaments, particularly in clinical trials where precise information is crucial, and existing communication systems are not cost-effective.

Innovation Solution

A sensor assembly for drug delivery devices that includes a housing with a switch and communication device, allowing for the detection and communication of injection status through electrical communication, enabling accurate monitoring and reporting of drug delivery events.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If traditional drug delivery devices are used without detection features, then the device complexity and cost are reduced, but the ability to confirm medicament administration and provide accurate injection status information is lost

Engineering Contradiction:
Improveinjection status detection accuracyVSAvoiddevice structure complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent extracts the detection function from the main drug delivery device by using a separate, removable sensor assembly that couples to the device. This sensor assembly contains the switch and communication device, allowing injection status detection without integrating complex detection systems into the core device structure.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent introduces a sensor assembly as an intermediary component between the drug delivery device and the data collection system. This sensor assembly with the switch and communication device acts as a mediator that detects injection status and transmits information without becoming part of the main device.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Loss of information

If existing communication systems are implemented in drug delivery devices, then injection status can be communicated, but the cost-effectiveness is reduced

Engineering Contradiction:
Improvedrug delivery information communicationVSAvoidmanufacturing cost
Core Design Contradiction:
Loss of informationVSEase of manufacture

Solution Approach 1:

The patent employs a cost-effective communication approach using a sensor assembly that can be coupled to and decoupled from the drug delivery device. The system uses straightforward electrical communication through a switch mechanism rather than expensive wireless or complex communication systems, reducing manufacturing costs while maintaining information communication capability.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

3Productivity

If no detection features are included in drug delivery devices, then manufacturing costs remain low, but accurate monitoring and reporting of drug delivery events cannot be achieved

Engineering Contradiction:
Improvedrug administration monitoring efficiencyVSAvoiddevice feature complexity
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The sensor assembly automatically detects injection status through the switch mechanism and communicates this information without requiring external intervention or complex processing systems. The system serves itself by capturing and transmitting data autonomously, improving monitoring efficiency without adding significant complexity.

Inventive Principle:
Principle #25Self-service

Data Source

PatentUS20230390501A1Drug Delivery Device with End-Of-Dose Detection
Publication Date: 2023.12.07 BECTON DICKINSON & CO
  • US20230390501A1 patent drawing
  • US20230390501A1 patent drawing
  • US20230390501A1 patent drawing

AI summary

Provided herein is a sensor assembly for a drug delivery device, including a housing defining an interior, the housing having at least one opening therein and being coupleable to a drug delivery device, a switch received at least partially within the interior and having an open configuration and a closed configuration, the switch configured to interact with a cooperating surface on the drug delivery device, and a communication device in electrical communication with the switch.